Product Images Lipitor

This text seems to show a graph or table with information about a cumulative hazard percentage and the effect of Atorvastatin on it. The hazard percentage ranges from 10 to 15, and a hazard ratio (HR) of 0.53 is also provided. There is also some indication of a timeline, with a four-year follow-up period. However, without more context, it is difficult to provide a more detailed description of the information being presented.*

This text seems to be a part of a clinical trial or study comparing the effectiveness of two cholesterol-lowering drugs, Horvastatin 10 mg and Sorvastatin 80 mg, in reducing the risk of cardiovascular events in patients. The table or graph shows the percentage of subjects experiencing "E vert" (which is not a clear term) for each drug, and the overall results suggest that Horvastatin 10 mg is more effective in reducing the risk of cardiovascular events. The HR (hazard ratio) is 0.78 with a confidence interval of 0.69-0.89, and the p-value is 0.0002. The time frame for the study is unclear.*

Distributed by Parke-Davis: Division of Pfizer Inc, NY, NY 10017.*

This text is a description of the distributor for a company called Parke-Davis, which is a division of Pfizer Inc. The address for the distributor is located in New York City.*

This appears to be the label of a medication called Lipitor, containing 90 tablets of 40mg Atorvastatin calcium, distributed by Pfizer Ireland Pharmaceuticals and stored at a controlled room temperature. The label also includes a product ID and recommended storage conditions.*